As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the commercial launch of its ...

A new 500-person study in Spain is investigating if daily kefir consumption can measurably change your gut microbiome.

The Food and Drug Administration has approved nine GLP-1 and dual GLP-1/GIP receptor agonist medications. Wegovy, a ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

LLY is expanding its revenue base beyond Mounjaro and Zepbound with new launches and label expansions that can strengthen long-term growth.

INSULIN COST CAP SUPPORT GROWS — More Senate Republicans are backing legislation to ensure diabetes patients with private insurance pay no more than $35 a month for insulin, David reports with ...

Every NHS patient in England deserves access to the right medicine, at the right time, wherever they live. Yet for common ...

Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Growth Index. Read more ...

Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...

Neticia Blunt-Waldron is the matriarch of her family at age 44. Each of the three women who held the title before her died of ...